Delivery Order SPE2DB22D3016-SPE2DB25FAUS0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $46,954.09 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. This firm fixed-price delivery order, awarded on June 2, 2025, is scheduled for completion by June 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, reflecting the contractor's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $34,908.00 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract was competitively awarded on August 20, 2025, with a firm fixed price structure and an ultimate completion date of September 11, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,981.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of GAMUNEX-C 40 Gram/400 ML Vial (400ML). The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order carries an ultimate completion date of October 6, 2025, and was awarded...
- The Defense Logistics Agency awarded a $23,272 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This non-set-aside contract, which carries an ultimate completion date of August 20, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 40 Gram/400 mL vials valued at $4,654.40 with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $23,272.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (40 gram/400 ml vial), with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract that will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a single transaction within AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 Gram/400 ML Vial (400ML) under a firm fixed-price contract valued at $2,327.20. The delivery order, which carries no set-aside designation, is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a routine pharmaceutical procurement to support military and...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials valued at $46,544.00. This is a firm fixed-price delivery order with an ultimate completion date of May 28, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $116,360 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 8, 2025, and performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, demonstrating the contractor's ability to compete...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAUS0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 ML vials valued at $23,272.00 under a firm fixed price contract. The order, issued on April 24, 2025, is due for completion by May 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is an unset-aside competitive award, reflecting AmerisourceBergen's proven capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its role as a prime vendor for the Defense Health Agency and other government healthcare systems, delivering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 4/24/25 |